Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramuscular Erwinaze/Erwinase pharmacokinetic study after E. coli asparaginase hypersensitivity in young adults with ALL or LBL
2014-000999-26Phase 2Terminated
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Jul 2014
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Asparaginase erwinia chrysanthemi in acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LL), sponsored by Jazz Pharmaceuticals plc. Started Jul 2014; status: terminated.
02
Drugs
Asparaginase erwinia chrysanthemi
03
Conditions
acute lymphoblastic leukemia (ALL)lymphoblastic lymphoma (LL)
Beyond the preview
Go deeper on 2014-000999-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000999-26.